Welcome to LookChem.com Sign In|Join Free
  • or
4-Boc-7-Bromo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine is a chemical compound with a molecular formula C16H21BrN2O2. It is a benzodiazepine derivative featuring a Boc (tert-butyloxycarbonyl) protecting group at the 4-position and a bromine atom at the 7-position. 4-Boc-7-Bromo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine is of interest in medicinal chemistry and drug research due to its structural similarity to known pharmaceuticals and its potential as a building block for the synthesis of novel bioactive molecules. The chemical properties and biological activities of 4-Boc-7-Bromo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine make it an intriguing target for further investigation in the development of new therapeutic agents.

886364-30-3

Post Buying Request

886364-30-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

886364-30-3 Usage

Uses

Used in Medicinal Chemistry:
4-Boc-7-Bromo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with improved therapeutic properties.
Used in Drug Research:
4-Boc-7-Bromo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine is used as a research tool in drug discovery. Its structural features and potential biological activities make it a valuable compound for studying the mechanisms of action and developing new therapeutic agents.
Used in Pharmaceutical Industry:
4-Boc-7-Bromo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine is used as a key building block in the synthesis of novel bioactive molecules. Its unique chemical properties and potential applications in medicinal chemistry contribute to the development of innovative drugs for various therapeutic areas.
Used in Chemical Synthesis:
4-Boc-7-Bromo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine is used as a versatile synthetic intermediate in organic chemistry. Its Boc protecting group and bromine atom at specific positions enable various synthetic transformations, facilitating the preparation of a wide range of chemical compounds with diverse applications.

Check Digit Verification of cas no

The CAS Registry Mumber 886364-30-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,3,6 and 4 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 886364-30:
(8*8)+(7*8)+(6*6)+(5*3)+(4*6)+(3*4)+(2*3)+(1*0)=213
213 % 10 = 3
So 886364-30-3 is a valid CAS Registry Number.
InChI:InChI=1/C14H19BrN2O2/c1-14(2,3)19-13(18)17-7-6-16-12-5-4-11(15)8-10(12)9-17/h4-5,8,16H,6-7,9H2,1-3H3

886364-30-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 7-bromo-1,2,3,5-tetrahydro-1,4-benzodiazepine-4-carboxylate

1.2 Other means of identification

Product number -
Other names 4-Boc-7-Bromo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:886364-30-3 SDS

886364-30-3Downstream Products

886364-30-3Relevant academic research and scientific papers

Design and synthesis of DNA-encoded libraries based on a benzodiazepine and a pyrazolopyrimidine scaffold

?kopi?, M. Klika,Bugain,Jung,Onstein,Brandherm,Kalliokoski,Brunschweiger

, p. 1957 - 1965 (2016)

Selection-based screening of large DNA-encoded libraries of drug-like small molecules is a validated method to identify bioactive compounds. Among the chemical space of bioactive compounds certain scaffold structures are well represented. These are commonly called "privileged scaffolds". We have synthesized DNA-encoded libraries based on two representatives of these scaffolds, a benzodiazepine and a pyrazolopyrimidine, and additionally a third library based on propargyl glycine. All three core structures possess a carboxylic acid to couple them to aminolinker-modified DNA. For subsequent library synthesis they contained an amino function to which a set of carboxylic acid building blocks were coupled, and a terminal alkyne that was reacted with a set of azides to furnish triazoles. The two sets of building blocks, 114 carboxylic acids and 104 azides, were selected with the help of chemoinformatic methods in order to control the physicochemical properties of the final libraries, remove unwanted substructures, and maximize diversity. The set of building blocks contained desthiobiotin allowing for validation of library synthesis. The DNA-encoded libraries were synthesized by split-and-pool combinatorial chemistry yielding three libraries that contain 28.254 compounds together. For DNA barcoding, 5′-phosphorylated double-stranded coding DNA sequences with four base overhangs were ligated with T4 ligase. The resulting DNA-encoded libraries were compared to bioactivity databases and, though being based on core structures well-established in medicinal chemistry, showed novelty with respect to the known bioactive chemical space.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 886364-30-3